FADD at the Crossroads between Cancer and Inflammation

Boldin, 1995, A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain, J. Biol. Chem., 270, 7795, 10.1074/jbc.270.14.7795 Chinnaiyan, 1995, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell, 81, 505, 10.1016/0092-8674(95)90071-3 Chaudhary, 1997, Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway, Immunity, 7, 821, 10.1016/S1074-7613(00)80400-8 Schneider, 1997, TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB, Immunity, 7, 831, 10.1016/S1074-7613(00)80401-X Kischkel, 1995, Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, EMBO J., 14, 5579, 10.1002/j.1460-2075.1995.tb00245.x Pyo, 2005, Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death, J. Biol. Chem., 280, 20722, 10.1074/jbc.M413934200 Osborn, 2010, Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis, Proc. Natl. Acad. Sci. U. S. A., 107, 13034, 10.1073/pnas.1005997107 Zhang, 2011, Functional complementation between FADD and RIP1 in embryos and lymphocytes, Nature, 471, 373, 10.1038/nature09878 Dillon, 2012, Survival function of the FADD-CASPASE-8-cFLIP(L) complex, Cell Rep., 1, 401, 10.1016/j.celrep.2012.03.010 Dillon, 2014, RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3, Cell, 157, 1189, 10.1016/j.cell.2014.04.018 Zhao, 2017, RIPK3 mediates necroptosis during embryonic development and postnatal inflammation in Fadd-deficient mice, Cell Rep., 19, 798, 10.1016/j.celrep.2017.04.011 Pasparakis, 2015, Necroptosis and its role in inflammation, Nature, 517, 311, 10.1038/nature14191 Zhang, 2016, MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 Inflammasome, Cell Rep., 16, 3247, 10.1016/j.celrep.2016.06.103 Zhang, 1998, Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1, Nature, 392, 296, 10.1038/32681 Scaffidi, 2000, Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase, J. Immunol., 164, 1236, 10.4049/jimmunol.164.3.1236 Hua, 2003, A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region, Immunity, 18, 513, 10.1016/S1074-7613(03)00083-9 Alappat, 2003, Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site, J. Biol. Chem., 278, 41585, 10.1074/jbc.C300385200 Screaton, 2003, Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis, Proc. Natl. Acad. Sci. U. S. A., 100, 5211, 10.1073/pnas.0431215100 Tourneur, 2010, FADD: a regulator of life and death, Trends Immunol., 31, 260, 10.1016/j.it.2010.05.005 Balachandran, 2004, A FADD-dependent innate immune mechanism in mammalian cells, Nature, 432, 401, 10.1038/nature03124 Ma, 2004, Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation, Nat. Immunol., 5, 380, 10.1038/ni1054 Newton, 2000, FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor, EMBO J., 19, 931, 10.1093/emboj/19.5.931 Henry, 2017, Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation, Mol. Cell, 65, 10.1016/j.molcel.2017.01.022 de Miguel, 2016, Onto better TRAILs for cancer treatment, Cell Death Differ., 23, 733, 10.1038/cdd.2015.174 von Karstedt, 2015, Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis, Cancer Cell, 27, 561, 10.1016/j.ccell.2015.02.014 Hartwig, 2017, The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2, Mol. Cell, 65, 10.1016/j.molcel.2017.01.021 Gaidt, 2016, Human monocytes engage an alternative inflammasome pathway, Immunity, 44, 833, 10.1016/j.immuni.2016.01.012 Kang, 2015, Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3, Nat. Commun., 6, 7515, 10.1038/ncomms8515 Gurung, 2014, FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes, J. Immunol., 192, 1835, 10.4049/jimmunol.1302839 Bolze, 2010, Whole-exome-sequencing-based discovery of human FADD deficiency, Am. J. Hum. Genet., 87, 873, 10.1016/j.ajhg.2010.10.028 Karki, 2017, Inflammasomes and cancer, Cancer Immunol. Res., 5, 94, 10.1158/2326-6066.CIR-16-0269 Petrilli, 2017, The multifaceted roles of inflammasome proteins in cancer, Curr. Opin. Oncol., 29, 35, 10.1097/CCO.0000000000000346 Kantono, 2017, Inflammasomes and cancer: the dynamic role of the inflammasome in tumor development, Front. Immunol., 8, 1132, 10.3389/fimmu.2017.01132 Wang, 2018, NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma, BMC Cancer, 18, 500, 10.1186/s12885-018-4403-9 Prapinjumrune, 2010, DNA amplification and expression of FADD in oral squamous cell carcinoma, J. Oral Pathol. Med., 39, 525 Ehlken, 2014, Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout, Cell Death Differ., 21, 1721, 10.1038/cdd.2014.83 El-Serag, 2011, Hepatocellular carcinoma, N. Engl. J. Med., 365, 1118, 10.1056/NEJMra1001683 Yamaoka, 1998, Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation, Cell, 93, 1231, 10.1016/S0092-8674(00)81466-X Courtois, 2001, NEMO/IKK gamma: linking NF-kappa B to human disease, Trends Mol. Med., 7, 427, 10.1016/S1471-4914(01)02154-2 Luedde, 2007, Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma, Cancer Cell, 11, 119, 10.1016/j.ccr.2006.12.016 Maeda, 2005, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014 Kondylis, 2015, NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis, Cancer Cell, 28, 582, 10.1016/j.ccell.2015.10.001 Hu, 2000, Activation of NF-kappaB by FADD, Casper, and caspase-8, J. Biol. Chem., 275, 10838, 10.1074/jbc.275.15.10838 Schaub, 2000, Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells, Nat. Med., 6, 790, 10.1038/77521 Tourneur, 2003, Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells, Oncogene, 22, 2795, 10.1038/sj.onc.1206399 Tourneur, 2008, Adenosine receptors control a new pathway of Fas-associated death domain protein expression regulation by secretion, J. Biol. Chem., 283, 17929, 10.1074/jbc.M802263200 Cimino, 2012, FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer, Br. J. Cancer, 106, 1989, 10.1038/bjc.2012.196 Wilkerson, 2013, The 11q13-q14 amplicon: clinicopathological correlations and potential drivers, Genes Chromosomes Cancer, 52, 333, 10.1002/gcc.22037 Chen, 2005, Phosphorylated FADD induces NF-κB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas, Proc. Natl. Acad. Sci., 102, 12507, 10.1073/pnas.0500397102 Gibcus, 2007, Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer, Clin. Cancer Res., 13, 6257, 10.1158/1078-0432.CCR-07-1247 Chien, 2016, Clinical implications of FADD gene amplification and protein overexpression in Taiwanese oral cavity squamous cell carcinomas, PLoS One, 11, 10.1371/journal.pone.0164870 Callegari, 2016, Copy number and expression analysis of FOSL1, GSTP1, NTSR1, FADD and CCND1 genes in primary breast tumors with axillary lymph node metastasis, Cancer Genet., 209, 331, 10.1016/j.cancergen.2016.06.003 Qin, 2016, Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis, Am. J. Hum. Genet., 98, 709, 10.1016/j.ajhg.2016.02.021 Balachandran, 2007, Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7, J. Immunol. 1950, 178, 2429, 10.4049/jimmunol.178.4.2429 Vilmont, 2015, Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD), Biochim. Biophys. Acta, 1853, 2885, 10.1016/j.bbamcr.2015.08.001 Jang, 2011, Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death, Cancer Res., 71, 7207, 10.1158/0008-5472.CAN-11-0760 Alappat, 2005, Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities, Mol. Cell, 19, 321, 10.1016/j.molcel.2005.06.024 Sheikh, 2003, The FADD is going nuclear, Cell Cycle, 2, 346, 10.4161/cc.2.4.421 Shimada, 2002, Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells, Jpn. J. Cancer Res., 93, 1164, 10.1111/j.1349-7006.2002.tb01219.x Shimada, 2004, Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis, Carcinogenesis, 25, 1089, 10.1093/carcin/bgh130 Matsuyoshi, 2006, FADD phosphorylation is critical for cell cycle regulation in breast cancer cells, Br. J. Cancer, 94, 532, 10.1038/sj.bjc.6602955 Schrijvers, 2012, FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 83, 1220, 10.1016/j.ijrobp.2011.09.060 Wachters, 2017, Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy, Laryngoscope, 127, E301, 10.1002/lary.26563 Patel, 2014, Increased expression of phosphorylated FADD in anaplastic large cell and other T-cell lymphomas, Biomark. Insights, 9, 77, 10.4137/BMI.S16553 Thapa, 2013, Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases, Proc. Natl. Acad. Sci. U. S. A., 110, E3109, 10.1073/pnas.1301218110 Oh, 2013, Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils, J. Immunol., 190, 4937, 10.4049/jimmunol.1202646 Zhou, 2016, The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target, Nat. Rev. Cancer, 16, 463, 10.1038/nrc.2016.49 Schinske, 2011, A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB, Mol. Cancer Ther., 10, 1807, 10.1158/1535-7163.MCT-11-0362 Zhuang, 2016, FADD is a key regulator of lipid metabolism, EMBO Mol. Med., 8, 895, 10.15252/emmm.201505924 Choi, 2017, SUMO-modified FADD recruits cytosolic Drp1 and caspase-10 to mitochondria for regulated necrosis, Mol. Cell. Biol., 37, 10.1128/MCB.00254-16 Fan, 2013, Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model, PLoS One, 8 Lee, 2012, Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis, Nat. Commun., 3, 978, 10.1038/ncomms1981 Goto, 2017, Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP, Biochem. Biophys. Res. Commun., 485, 152, 10.1016/j.bbrc.2017.02.040 Feltham, 2017, The small molecule that packs a punch: ubiquitin-mediated regulation of RIPK1/FADD/caspase-8 complexes, Cell Death Differ., 24, 1196, 10.1038/cdd.2017.67 Seo, 2018, K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death, Oncogene, 37, 4994, 10.1038/s41388-018-0323-z Wang, 2012, FADD cleavage by NK cell granzyme M enhances its self-association to facilitate procaspase-8 recruitment for auto-processing leading to caspase cascade, Cell Death Differ., 19, 605, 10.1038/cdd.2011.130 de Poot, 2013, Granzyme M cannot induce cell death via cleavage of mouse FADD, Apoptosis, 18, 533, 10.1007/s10495-013-0810-1 Li, 2013, Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains, Nature, 501, 242, 10.1038/nature12436 Pearson, 2013, A type III effector antagonizes death receptor signalling during bacterial gut infection, Nature, 501, 247, 10.1038/nature12524 Coburn, 2007, Type III secretion systems and disease, Clin. Microbiol. Rev., 20, 535, 10.1128/CMR.00013-07 Newton, 2010, The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65, PLoS Pathog., 6, 10.1371/journal.ppat.1000898 Gao, 2013, NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation, Cell Host Microbe, 13, 87, 10.1016/j.chom.2012.11.010 Scott, 2017, The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD), J. Biol. Chem., 292, 17337, 10.1074/jbc.M117.805036 Imtiyaz, 2009, The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation, J. Biol. Chem., 284, 9917, 10.1074/jbc.M900249200 Gómez-Angelats, 2003, Molecular evidence for the nuclear localization of FADD, Cell Death Differ., 10, 791, 10.1038/sj.cdd.4401237 Tourneur, 2005, FADD adaptor in cancer, Med. Immunol., 4, 1, 10.1186/1476-9433-4-1 Siegel, 1998, Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis, J. Cell Biol., 141, 1243, 10.1083/jcb.141.5.1243 Kriebardis, 2008, RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components, Transfusion, 48, 1943, 10.1111/j.1537-2995.2008.01794.x Jinesh, 2012, Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL, J. Leukoc. Biol., 92, 233, 10.1189/jlb.1211623 Kepp, 2017, Extracellular nucleosides and nucleotides as immunomodulators, Immunol. Rev., 280, 83, 10.1111/imr.12571 Oliveto, 2017, Role of microRNAs in translation regulation and cancer, World J. Biol. Chem., 8, 45, 10.4331/wjbc.v8.i1.45 Mi, 2007, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia, Proc. Natl. Acad. Sci. U. S. A., 104, 19971, 10.1073/pnas.0709313104 Yamada, 2014, Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD), Biochim. Biophys. Acta, 1843, 590, 10.1016/j.bbamcr.2013.11.022 Yan, 2017, Long noncoding RNA H19/miR-675 axis promotes gastric cancer via FADD/caspase 8/caspase 3 signaling pathway, Cell. Physiol. Biochem., 42, 2364, 10.1159/000480028 Liu, 2016, MiR-7a is an important mediator in Fas-associated protein with death domain (FADD)-regulated expression of focal adhesion kinase (FAK), Oncotarget, 7, 51393, 10.18632/oncotarget.9838 Rochat-Steiner, 2000, FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation, J. Exp. Med., 192, 1165, 10.1084/jem.192.8.1165 Jang, 2011, Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD, Oncogene, 30, 471, 10.1038/onc.2010.423 Kim, 2014, The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth, Nat. Commun., 5, 3351, 10.1038/ncomms4351 Smith, 1997, Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase, Biochem. Biophys. Res. Commun., 234, 397, 10.1006/bbrc.1997.6633 Bowman, 2015, Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer, Sci. Signal., 8, 10.1126/scisignal.2005607 Herbst, 2008, Lung cancer, N. Engl. J. Med., 359, 1367, 10.1056/NEJMra0802714 Khan, 2010, High-throughput molecular imaging for the identification of FADD kinase inhibitors, J. Biomol. Screen., 15, 1063, 10.1177/1087057110380570 Bannerman, 2002, The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta, J. Clin. Invest., 109, 419, 10.1172/JCI0214774